Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06262022
Other study ID # KaramanogluMehmetbeyUFGok
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 15, 2024
Est. completion date April 30, 2024

Study information

Verified date February 2024
Source Karamanoglu Mehmetbey University
Contact fatma gök
Phone 05544906142
Email fatmagok123@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, we aimed to investigate the effect of cold application applied for 20 minutes every hour for 8 hours on the first day, second and third days after total hip arthroplasty with gel pads, on the pain level, edema and drainage amount of total hip arthroplasty patients. The main question[s]it aims to answer are: - Is there a difference between the pain levels of patients in the control and cold application arms? - Is there a difference between the knee edema of patients in the control and cold application arms? - Is there a difference between the amount of drainage of patients in the control and cold application arms? This study was planned as a prospective, parallel, two-arm (1:1) randomized controlled trial (RCT).


Description:

- When the patient arrives at the service after TKA, cold application will begin with gel pads at 0 ÂșC and continue for eight hours. After TKA, cold application will continue for 20 minutes every hour between 08.00-16.00 on the 1st and 2nd day. - After TKA, pain intensity will be evaluated and at the 6th, 24th and 48th hours. - Knee circumference measurements for knee edema will be made before TKA and at the 24th and 48th hours after TKA. - After being taken to bed after TKA, the amount of drainage will be measured at the 1st, 6th and 24th hours. - In the first 24 hours and 24-48 hours after TKA. Analgesic consumption between hours will be recorded. - Knee temperature will be measured before and after each cold application. - Knee temperature will be measured before and after each cold application. Measurements of the control group will be made at the specified times in the cold application group. Cold application will not be applied to the control group.


Recruitment information / eligibility

Status Recruiting
Enrollment 78
Est. completion date April 30, 2024
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years and above, - Able to communicate verbally and in writing, - Turkish speaking, - TKA applied for the first time, - Unilateral total knee arthroplasty applied, - Spinal anesthesia applied, - Having a hemovac drainage catheter, - Without peripheral vascular disease, Exclusion Criteria: - Revision total knee arthroplasty applied, - Bilateraltotal knee arthroplasty applied, - Those who use alcohol and substances, - TKA was performed for a reason other than knee osteoarthritis, - General anesthesia applied,

Study Design


Related Conditions & MeSH terms


Intervention

Other:
cold therapy
A cold ice pack will be applied to the patient's knee for 20 minutes every hour for three days, starting after total knee arthroplasty.

Locations

Country Name City State
Turkey Karamanoglu Mehmet bey Üniversitesi Merkez Karaman

Sponsors (2)

Lead Sponsor Collaborator
Karamanoglu Mehmetbey University Karaman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Analgesic consumption The type and amount of analgesics used by patients after total knee arthroplasty will be recorded. The first 24 hours and 24-48 hours after total knee arthroplasty. Analgesic consumption between hours will be recorded.
Primary pain level Pain level of patients will be measured after total knee arthroplasty ( Visual Analogue Scale (VAS) is a 10 cm ruler with "no pain" written on one end and "the worst possible pain" written on the other end. Patients mark the levels on the ruler according to their pain levels. 1-3 points on the scale are rated as mild, 4-6 points as moderate and 7-10 points as severe pain.) After total knee arthroplasty, pain intensity will be evaluated at the 6th, 24th and 48th hours.
Secondary edema The knee circumference of patients will be measured before total knee arthroplasty and will be measured again at 24 and 48 hours after surgery. Knee circumference measurements for knee edema will be made before total knee arthroplasty and at the 24th and 48th hours after total knee arthroplasty.
Secondary amount of drainage The amount coming from the drain after total knee arthroplasty will be measured After being taken to bed after total knee arthroplasty, the amount of drainage will be measured at the 1st, 6th and 24th hours.
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2